FDA
-
-
-
-
-
-
-
Angle PLC: Transfer of Lock-in Shares
-
-
-
-
-
-
-
ANGLE plc: Result of General Meeting
-
-
-
-
-
-
-
Angle's Parsortix(TM) System Showcased in Multiple Presentations at Leading European Circulating Tumour Cell Conference
-
-
-
-
-
-
-
Preclinical Study Using Parsortix Presented at Tumor Models Boston Summit
-
-
-
-
-
-
-
Angle PLC: Parsortix enables analysis in head and neck cancer
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

